Literature DB >> 19137200

A national strategy for the management of chronic obstructive pulmonary disease (COPD) in England: aiming to improve the quality of care for patients.

Kevin Gruffydd-Jones1.   

Abstract

This article examines the rationale behind the development of the National Clinical Strategy for Chronic Obstructive Pulmonary Disease (COPD) in England which will be launched in 2009. It focuses on the burden which COPD places on the healthcare service and the effect it has on patients, and highlights the important steps in the development of the Clinical Strategy. The general recommendations which are likely to be contained within the Clinical Strategy are discussed, as well as the possible implications for primary care.

Entities:  

Mesh:

Year:  2008        PMID: 19137200      PMCID: PMC6619913          DOI: 10.3132/pcrj.2008.00071

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  9 in total

1.  Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach.

Authors:  Rachel E Jordan; Kin-bong Hubert Lam; Kar Keung Cheng; Martin R Miller; Jennifer L Marsh; Jon G Ayres; David Fitzmaurice; Peymané Adab
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

Review 2.  The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.

Authors:  Barbara P Yawn; Ibrahim Raphiou; Judith S Hurley; Anand A Dalal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

3.  Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe.

Authors:  Paul W Jones; Guy Brusselle; Roberto W Dal Negro; Montse Ferrer; Peter Kardos; Mark L Levy; Thierry Perez; Juan José Soler Cataluña; Thys van der Molen; Lukasz Adamek; Norbert Banik
Journal:  Prim Care Respir J       Date:  2012-09

4.  Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study.

Authors:  Anamika Jithoo; Paul L Enright; Peter Burney; A Sonia Buist; Eric D Bateman; Wan C Tan; Michael Studnicka; Filip Mejza; Suzanne Gillespie; William M Vollmer
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

5.  A qualitative study of patients' goals and expectations for self-management of COPD.

Authors:  Kathryn Wortz; Angela Cade; James Ryan Menard; Sue Lurie; Kristine Lykens; Sejong Bae; Bradford Jackson; Fenghsiu Su; Karan Singh; David Coultas
Journal:  Prim Care Respir J       Date:  2012-12

Review 6.  Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care.

Authors:  Shahrzad M Lari; Davood Attaran; Mohammad Tohidi
Journal:  Patient Relat Outcome Meas       Date:  2014-11-10

7.  Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care.

Authors:  Annerika H M Slok; Daniel Kotz; Gerard van Breukelen; Niels H Chavannes; Maureen P M H Rutten-van Mölken; Huib A M Kerstjens; Thys van der Molen; Guus M Asijee; P N Richard Dekhuijzen; Sebastiaan Holverda; Philippe L Salomé; Lucas M A Goossens; Mascha Twellaar; Johannes C C M In 't Veen; Onno C P van Schayck
Journal:  BMJ Open       Date:  2016-07-11       Impact factor: 2.692

8.  ABC Index: quantifying experienced burden of COPD in a discrete choice experiment and predicting costs.

Authors:  Lucas M A Goossens; Maureen P M H Rutten-van Mölken; Melinde R S Boland; Bas Donkers; Marcel F Jonker; Annerika H M Slok; Philippe L Salomé; Onno C P van Schayck; Johannes C C M In 't Veen; Elly A Stolk
Journal:  BMJ Open       Date:  2017-12-26       Impact factor: 2.692

9.  Diagnostic accuracy of a pocket screening spirometer in diagnosing chronic obstructive pulmonary disease in general practice: a cross sectional validation study using tertiary care as a reference.

Authors:  Marina Labor; Žarko Vrbica; Ivan Gudelj; Slavica Labor; Davor Plavec
Journal:  BMC Fam Pract       Date:  2016-08-19       Impact factor: 2.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.